VIVS
Price:
$2.29
Market Cap:
$5.97M
VivoSim Labs, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised of mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company's lead candidate is FXR314, which is phase 2/3clinical trial for indication of inflammatory bowel disease with a clinical focus on ulcerative colitis; and completed phase 1 clinical trial for the indication of liver fibrosis with a clinical focus steatohepatitis. Org...[Read more]
Industry
Biotechnology
IPO Date
2012-02-14
Stock Exchange
NASDAQ
Ticker
VIVS
According to VivoSim Labs, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 4.49. This represents a change of -2770.79% compared to the average of -0.17 of the last 4 quarters.
The mean historical PE Ratio of VivoSim Labs, Inc. over the last ten years is -0.15. The current 4.49 PE Ratio has changed -303683.44% with respect to the historical average. Over the past ten years (40 quarters), VIVS's PE Ratio was at its highest in in the March 2025 quarter at 0.09. The PE Ratio was at its lowest in in the June 2025 quarter at -0.32.
Average
-0.15
Median
-0.05
Minimum
-1.01
Maximum
-0.02
Discovering the peaks and valleys of VivoSim Labs, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.03%
Maximum Annual PE Ratio = -0.02
Minimum Annual Increase = -33.60%
Minimum Annual PE Ratio = -1.01
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -1.01 | 1.03% |
| 2024 | -0.09 | 23.47% |
| 2023 | -0.07 | -33.60% |
| 2022 | -0.11 | 85.34% |
| 2021 | -0.06 | 18.48% |
| 2020 | -0.05 | 59.85% |
| 2019 | -0.03 | 40.58% |
| 2018 | -0.02 | 21.18% |
| 2017 | -0.02 | 8.92% |
| 2016 | -0.02 | -11.83% |
The current PE Ratio of VivoSim Labs, Inc. (VIVS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.39
5-year avg
-0.27
10-year avg
-0.15
VivoSim Labs, Inc.’s PE Ratio is greater than Quoin Pharmaceuticals, Ltd. (-0.91), greater than Pasithea Therapeutics Corp. (-0.00), greater than Cyclerion Therapeutics, Inc. (-2.49), greater than Alaunos Therapeutics, Inc. (-1947.11), greater than PharmaCyte Biotech, Inc. (-7.31), greater than Polyrizon Ltd. (-21.85), greater than NovaBay Pharmaceuticals, Inc. (1.91), greater than Radiopharm Theranostics Limited (0), greater than XTL Biopharmaceuticals Ltd. (-4.13), greater than Impact BioMedical Inc. (-0.15),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.91 | $11.12M | |
| -0.00 | $8.63M | |
| -2.49 | $5.67M | |
| -1947.11 | $8.01M | |
| -7.31 | $8.22M | |
| -21.85 | $14.21M | |
| 1.91 | $6.55M | |
| 0 | $5.91M | |
| -4.13 | $4.76M | |
| -0.15 | $5.88M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like VivoSim Labs, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like VivoSim Labs, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is VivoSim Labs, Inc.'s PE Ratio?
How is the PE Ratio calculated for VivoSim Labs, Inc. (VIVS)?
What is the highest PE Ratio for VivoSim Labs, Inc. (VIVS)?
What is the 3-year average PE Ratio for VivoSim Labs, Inc. (VIVS)?
What is the 5-year average PE Ratio for VivoSim Labs, Inc. (VIVS)?
How does the current PE Ratio for VivoSim Labs, Inc. (VIVS) compare to its historical average?